Find and Pitch Jounalists, Get Your Story Covered

Tags: Deal Evergreen Deals Commerce 2023 Deal Mobile

	Profile	Recent Articles on Subject
1	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Approves Guselkumab for Treatment of Ulcerative Colitis - 6 days ago FDA Extends Approval of Fibryga to Include Bleeding Patients With Acquired Fibrinogen Deficiency - about 2 months ago FDA Grants Orphan Drug Designation to ZMA001 for Pulmonary Arterial Hypertension - about 2 months ago Luspatercept Reduces Transfusion Burden Compared With Epoetin Alfa - 3 months ago FDA Grants Accelerated Approval for Elafibranor as Treatment of Primary Biliary Cholangitis - 3 months ago New Data Shows Positive Results for Sotagliflozin for Patients With Chronic Kidney Disease, Diabetes - 5 months ago FDA Approves Expanded Indication for Tenofovir Alafenamide as Hepatitis B Treatment - 6 months ago FDA Approves Vadadustat for Oral Treatment of Anemia Due to Chronic Kidney Disease - 6 months ago FDA Approves Sotatercept-csrk for Pulmonary Arterial Hypertension - 6 months ago FDA Approves Macitentan, Tadalafil Combination Tablet for PAH - 6 months ago FDA Expands Label for Bempedoic Acid to Reduce Cardiovascular Risk, With or Without Statins - 6 months ago FDA Approves Aprocitentan for Treatment of Hypertension in Combination With Other Drugs - 6 months ago FDA Accepts Supplemental New Drug Application for Adagrasib for Colorectal Cancer - 7 months ago FDA Approves Targeted Release Budesonide for Treatment of Primary Immunoglobulin A Nephropathy - 9 months ago FDA Approves Enfortumab Vedotin, Pembrolizumab for Treatment of Urothelial Cancer - 9 months ago Biosimilar Candidate GP40141 Found Similar to Romiplostim for Idiopathic Thrombocytopenic Purpura - 10 months ago FDA Approves Defencath for Catheter-Related Infections for Those With Kidney Failure - 10 months ago TAK-279 Demonstrates Improvements in ACR 20 Response for Psoriatic Arthritis - 11 months ago FDA Approves Empagliflozin for Adults With Chronic Kidney Disease at Risk of Progression - 12 months ago FDA Accepts Supplemental Biologics License Application of Altuviiio for Children With Severe Hemophilia A - 12 months ago
2	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Novel Agent Reduces Monthly Migraine Days - 14 days ago ALS Therapy to Be Pulled From the Market, Drugmaker Says - 6 months ago
3	PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	MHRA approves Astellas’ Vyloy combination for gastric cancer - 27 days ago
4	Ed Susman MedPage Today Freelance Medical journalist. Owns medical site. West Palm Beach, Florida medical journalismwritinghealthcare	With Ticagrelor, Aspirin May Not Be Needed After PCI for Acute Coronary Syndrome - 5 months ago
5	Aislinn Antrim, Assistant Managing Editor Pharmacy Times Journalist at Pharmacy Times. UNC graduate. PoliticsStorytellingCats	Study: Empagliflozin Reduces MACE Regardless of Baseline Albuminuria Levels - 5 months ago
6	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: Alnylam’s twice-a-year drug lowered blood pressure when combined with common pills - 5 months ago
7	Nicole Lou MedPage Today Medical reporter @medpagetoday. Bird advocate. undisclosed remote location medical reporting	ACC Meeting to Make Noise on Beta-Blockers, SGLT2i, Chelation Therapy for Acute MI - 6 months ago Expanded Label Officially Makes Bempedoic Acid a CVD Prevention Medication - 6 months ago Most Popular DOAC Holds Its Own Against Edoxaban in Those Age 80 and Up - 6 months ago Statins and CKD; Farxiga's Limited Symptom Improvement; Stop Wasted TNKase - 9 months ago OCEANIC-AF Trial Sunk; Second Renal Denervation Device Approved; Strep-Stroke Link? - 10 months ago Alteplase Not Harmful in NOAC Users, Even in a More Bleeding-Prone Cohort - 10 months ago Alleged Stroke Trial Misconduct; Ultrasound Tx for Severe AS; Farxiga's eGFR Drops - 10 months ago
8	Rick Lange, MD, Texas Tech; Elizabeth Tracey MedPage Today Texas Tech University System, advancing higher education and health care. Lubbock, Texas higher educationhealth care	Aspirin for Fatty Liver; Meds for Self-Managed Abortion - 6 months ago
9	Kristen Monaco MedPage Today	Once-Rejected Drug Now FDA Approved for CKD-Related Anemia - 6 months ago One Class of Antidiabetic Linked With Lower Kidney Stone Risk - 8 months ago In Acute Kidney Disease, SGLT2 inhibitors Were All-Around Protective - 9 months ago Quick Albuminuria Reduction Key Factor in Finerenone's Efficacy - 10 months ago Methotrexate Tied to Greater Risks for Older Patients With CKD - 10 months ago FDA OKs Product to Thwart Bloodstream Infections During Dialysis - 10 months ago Sparsentan Bests Irbesartan for Preserving Kidney Function in IgA Nephropathy - 11 months ago Sparsentan Failed to Preserve Kidney Function Over Time in FSGS - 11 months ago FDA Approves First Phosphate Absorption Inhibitor for CKD - 11 months ago FDA Approves Another SGLT2 Inhibitor for Treating CKD - 12 months ago
10	Jennifer Gershman, PharmD, CPh, PACS Pharmacy Times Pharmacist. Writes for Pharmacy Times, GoodRx. PharmacyHealthcare	Help Patients Manage Heart Health Through Medication Therapy Management - 7 months ago

Journalists covering Allopurinol Tablets